EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.7.4.10 | Adenocarcinoma of Lung |
30696468 |
Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1? to drive lung adenocarcinoma metastasis. |
causal interaction diagnostic usage therapeutic application unassigned |
4 1 4 0 |
2.7.4.10 | Breast Neoplasms |
32956623 |
Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m6A-Based Epitranscriptomic Mechanism. |
ongoing research therapeutic application unassigned |
3 1 0 |
2.7.4.10 | Breast Neoplasms |
34213887 |
ATF3 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an N6-Methyladenosine-Based Epitranscriptomic Mechanism. |
therapeutic application unassigned |
1 0 |
2.7.4.10 | Carcinogenesis |
31463832 |
Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 4 0 |
2.7.4.10 | Clonorchiasis |
29580315 |
Recombinant adenylate kinase 3 from liver fluke Clonorchis sinensis for histochemical analysis and serodiagnosis of clonorchiasis. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 4 2 4 |
2.7.4.10 | Lung Neoplasms |
30696468 |
Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1? to drive lung adenocarcinoma metastasis. |
causal interaction diagnostic usage therapeutic application unassigned |
4 1 4 0 |
2.7.4.10 | Malaria |
22819813 |
Subcellular localization of adenylate kinases in Plasmodium falciparum. |
unassigned |
0 |
2.7.4.10 | Neoplasm Metastasis |
30696468 |
Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1? to drive lung adenocarcinoma metastasis. |
causal interaction diagnostic usage therapeutic application unassigned |
4 1 4 0 |
2.7.4.10 | Neoplasms |
17203974 |
Identification of specific protein markers in microdissected hepatocellular carcinoma. |
causal interaction diagnostic usage unassigned |
3 4 0 |
2.7.4.10 | Neoplasms |
26980435 |
Modulation of anti-cancer drug sensitivity through the regulation of mitochondrial activity by adenylate kinase 4. |
causal interaction unassigned |
4 0 |